NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning

Antibodies are a rapidly growing class of therapeutics. Recently, single domain camelid VHH antibodies, and their recognition nanobody domain (Nb) appeared as a cost-effective highly stable alternative to full-length antibodies. There is a growing need for high-throughput epitope mapping based on ac...

Full description

Bibliographic Details
Main Authors: Tomer Cohen, Matan Halfon, Dina Schneidman-Duhovny
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.958584/full